Module
Hepatitis JournalOptions – September/October 2005
Source: Journal Options
Hepatitis JournalOptions – September/October 2005
CME Program Director: Robert G. Gish, MD, David L. Thomas, MD, MPH
  
- Hal B. Jenson, MD, MBA
- Emmet B. Keeffe, MD, MACP
- Daryl T-Y Lau, MD, MSc, MPH, FRCP(C)
|
 
- Paul Martin, MD
- Philip Rosenthal, MD
- Richard K. Sterling, MD
|
|
Learning Objectives
Upon completion of this activity, participants should be able to:
- Describe the results of recent studies of diagnostic tests for viral hepatitis and its complications, including fibrosis, cirrhosis, and hepatocellular carcinoma.
- Review the epidemiology, pathogenesis, and natural history of hepatitis.
- Discuss the latest treatments, both approved and experimental, for hepatitis and its complications.
|
Disclaimer: The materials published on the Clinical Care Options
Web site reflect the views of the reviewers or authors of the
CCO
material, not those of Clinical Care Options, LLC, the CME provider,
or the companies providing educational grants. The materials may
discuss uses and dosages for therapeutic products that have not been
approved by the United States Food and Drug Administration. A qualified
healthcare professional should be consulted before using any therapeutic
product discussed. Readers should verify all information and data before
treating patients or using any therapies described in these materials.
|
Jointly sponsored by University of Alabama School of Medicine and Clinical Care Options, LLC.
Contact Info
Educational grants provided by:
Educational grants support only the CME-certified components of this program.
|
|